Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 12.0B | 9.4B | 8.5B | 13.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.5B | 3.2B | 3.5B | 3.2B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 215M | 218M | 181M | 202M |
Other income expense | 273M | 222M | 189M | 200M |
Pretax income | 1.3B | 1.3B | 1.6B | 892M |
Tax provision | 113M | 196M | 197M | 193M |
Net income | 1.2B | 1.1B | 1.4B | 699M |
Basic EPS | 1.2 | 1.1 | — | 0.6 |
Diluted EPS | 1.2 | 1.1 | — | 0.6 |
Basic average shares | 642.1M | 643M | — | 647.1M |
Diluted average shares | 648M | 648.1M | — | 650.8M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.3B | 1.3B | 1.6B | 892M |
Minority interests | -405M | -420M | -484M | -315M |
Preferred stock dividends | 13M | — | — | — |